Serpina3n: Potential drug and challenges, mini review

References

• Forsyth S, Horvath A, Coughlin P. A review and comparison of the murine alpha1-antitrypsin and alpha1-antichymotrypsin multigene clusters with the human clade A serpins. Genomics. 2003;81(3):336–345.
   PubMed Web of Science ®Google Scholar
• Horvath AJ, Forsyth SL, Coughlin PB. Expression patterns of murine antichymotrypsin-like genes reflect evolutionary divergence at the Serpina3 locus. J Mol Evol. 2004;59(4):488–497.
   PubMed Web of Science ®Google Scholar
• Bodmer JL, Schnebli HP. Plasma proteinase inhibitors. Schweiz Med Wochenschr. 1984;114(40):1359–1363.
   PubMedGoogle Scholar
• Chandra T, Stackhouse R, Kidd VJ. Sequence homology between human alpha 1-antichymotrypsin, alpha 1-antitrypsin, and antithrombin III. Biochemistry. 1983;22(22):5055–5061.
   PubMed Web of Science ®Google Scholar
• Heit C, Jackson BC, McAndrews M, et al. Update of the human and mouse SERPIN gene superfamily. Hum Genomics. 2013;7(1):22.
   PubMedGoogle Scholar
• Hsu I, Parkinson LG, Shen Y, et al. Serpina3n accelerates tissue repair in a diabetic mouse model of delayed wound healing. Cell Death Dis. 2014;5(10):e1458.
   PubMedGoogle Scholar
• Horvath AJ, Irving JA, Rossjohn J, et al. The murine orthologue of human antichymotrypsin: a structural paradigm for clade A3 serpins. J Biol Chem. 2005;280(52):43168–43178.
   PubMed Web of Science ®Google Scholar
• Sipione S, Simmen KC, Lord SJ, et al. Identification of a novel human granzyme B inhibitor secreted by cultured sertoli cells. J Immunol. 2006;177(8):5051–5058.
   PubMed Web of Science ®Google Scholar
• Gettins PG. Serpin structure, mechanism, and function. Chem Rev. 2002;102(12):4751–4804.
   PubMed Web of Science ®Google Scholar
• Ang LS, Boivin WA, Williams SJ, et al. Serpina3n attenuates granzyme B-mediated decorin cleavage and rupture in a murine model of aortic aneurysm. Cell Death Dis. 2011;2(9):e209.
   PubMedGoogle Scholar
• Hoffmann DC, Textoris C, Oehme F, et al. Pivotal role for alpha1-antichymotrypsin in skin repair. J Biol Chem. 2011;286(33):28889–28901.
   PubMed Web of Science ®Google Scholar
• Haile Y, Carmine-Simmen K, Olechowski C, et al. Granzyme B-inhibitor serpina3n induces neuroprotection in vitro and in vivo. J Neuroinflammation. 2015;12(1):157.
   PubMedGoogle Scholar
• Vicuna L, Strochlic DE, Latremoliere A, et al. The serine protease inhibitor SerpinA3N attenuates neuropathic pain by inhibiting T cell-derived leukocyte elastase. Nat Med. 2015;21(5):518–523.
   PubMed Web of Science ®Google Scholar
• Tjondrokoesoemo A, Schips T, Kanisicak O, et al. Genetic overexpression of Serpina3n attenuates muscular dystrophy in mice. Hum Mol Genet. 2016;25(6):1192–1202.
   PubMed Web of Science ®Google Scholar
• Coronado MJ, Brandt JE, Kim E, et al. Testosterone and interleukin-1beta increase cardiac remodeling during coxsackievirus B3 myocarditis via serpin A 3n. Am J Physiol Heart Circ Physiol. 2012;302(8):H1726–36.
   PubMed Web of Science ®Google Scholar
• Ishida M, Kawao N, Okada K, et al. Serpina3n, dominantly expressed in female osteoblasts, suppresses the phenotypes of differentiated osteoblasts in mice. Endocrinology. 2018;159(11):3775–3790.
   PubMed Web of Science ®Google Scholar
• Zamanian JL, Xu L, Foo LC, et al. Genomic analysis of reactive astrogliosis. J Neurosci. 2012;32(18):6391–6410.
   PubMed Web of Science ®Google Scholar
• Patterson SD, Bell K, Shaw DC. The equine major plasma serpin multigene family: partial characterization including sequence of the reactive-site regions. Biochem Genet. 1991;29(9–10):477–499.
   PubMed Web of Science ®Google Scholar
• Potempa J, Korzus E, Travis J. The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J Biol Chem. 1994;269(23):15957–15960.
   PubMed Web of Science ®Google Scholar
• Irving JA, Pike RN, Lesk AM, et al. Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function. Genome Res. 2000;10(12):1845–1864.
   PubMed Web of Science ®Google Scholar
• Silverman GA, Bird PI, Carrell RW, et al. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem. 2001;276(36):33293–33296.
   PubMed Web of Science ®Google Scholar
• Selawry HP, Cameron DF. Sertoli cell-enriched fractions in successful islet cell transplantation. Cell Transplant. 1993;2(2):123–129.
   PubMed Web of Science ®Google Scholar
• Korbutt GS, Elliott JF, Rajotte RV. Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression. Diabetes. 1997;46(2):317–322.
   PubMed Web of Science ®Google Scholar
• Suarez-Pinzon W, Korbutt GS, Power R, et al. Testicular sertoli cells protect islet beta-cells from autoimmune destruction in NOD mice by a transforming growth factor-beta1-dependent mechanism. Diabetes. 2000;49(11):1810–1818.
   PubMed Web of Science ®Google Scholar
• Takeda Y, Gotoh M, Dono K, et al. Protection of islet allografts transplanted together with Fas ligand expressing testicular allografts. Diabetologia. 1998;41(3):315–321.
   PubMed Web of Science ®Google Scholar
• Janciauskiene S. Conformational properties of serine proteinase inhibitors (serpins) confer multiple pathophysiological roles. Biochim Biophys Acta. 2001;1535(3):221–235.
   PubMed Web of Science ®Google Scholar
• Licastro F, Campbell IL, Kincaid C, et al. A role for apoE in regulating the levels of alpha-1-antichymotrypsin in the aging mouse brain and in Alzheimer's disease. Am J Pathol. 1999;155(3):869–875.
   PubMed Web of Science ®Google Scholar
• Licastro F, Candore G, Lio D, et al. Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun Ageing. 2005;2(1):8.
   PubMedGoogle Scholar
• Sardi F, Fassina L, Venturini L, et al. Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly. Autoimmun Rev. 2011;11(2):149–153.
   PubMed Web of Science ®Google Scholar
• Zhou J, Cheng Y, Tang L, et al. Up-regulation of SERPINA3 correlates with high mortality of melanoma patients and increased migration and invasion of cancer cells. Oncotarget. 2017;8(12):18712–18725.
   PubMedGoogle Scholar
• Li Y, Dong X, Cai J, et al. SERPINA3 induced by astroglia/microglia co-culture facilitates glioblastoma stem-like cell invasion. Oncol Lett. 2018;15(1):285–291.
   PubMed Web of Science ®Google Scholar
• Law RH, Zhang Q, McGowan S, et al. An overview of the serpin superfamily. Genome Biol. 2006;7(5):216.
   PubMed Web of Science ®Google Scholar
• Huntington JA. Serpin structure, function and dysfunction. J Thromb Haemost. 2011;9(Suppl 1):26–34.
   PubMedGoogle Scholar
• Bots M, Medema JP. Serpins in T cell immunity. J Leukoc Biol. 2008;84(5):1238–1247.
   PubMed Web of Science ®Google Scholar
• Kaiserman D, Bird PI. Control of granzymes by serpins. Cell Death Differ. 2010;17(4):586–595.
   PubMed Web of Science ®Google Scholar
• Davies MJ, Lomas DA. The molecular aetiology of the serpinopathies. Int J Biochem Cell Biol. 2008;40(6–7):1273–1286.
   PubMed Web of Science ®Google Scholar
• Laursen I, Lykkesfeldt AE. Purification and characterization of an alpha 1-antichymotrypsin-like 66 kDa protein from the human breast cancer cell line, MCF-7. Biochim Biophys Acta. 1992;1121(1–2):119–129.
   PubMedGoogle Scholar
• Higashiyama M, Doi O, Yokouchi H, et al. Alpha-1-antichymotrypsin expression in lung adenocarcinoma and its possible association with tumor progression. Cancer. 1995;76(8):1368–1376.
   PubMed Web of Science ®Google Scholar
• Clemmensen SN, Jacobsen LC, Rorvig S, et al. Alpha-1-antitrypsin is produced by human neutrophil granulocytes and their precursors and liberated during granule exocytosis. Eur J Haematol. 2011;86(6):517–530.
   PubMed Web of Science ®Google Scholar
• Gooptu B, Hazes B, Chang WS, et al. Inactive conformation of the serpin alpha(1)-antichymotrypsin indicates two-stage insertion of the reactive loop: implications for inhibitory function and conformational disease. Proc Natl Acad Sci U S A. 2000;97(1):67–72.
   PubMed Web of Science ®Google Scholar
• Saunders DN, Tindall EA, Shearer RF, et al. A novel SERPINA1 mutation causing serum alpha(1)-antitrypsin deficiency. PLoS One. 2012;7(12):e51762.
   PubMed Web of Science ®Google Scholar
• Rabieian R, Boshtam M, Zareei M, et al. Plasminogen Activator Inhibitor Type-1 as a Regulator of Fibrosis. J Cell Biochem. 2018;119(1):17–27.
   PubMed Web of Science ®Google Scholar
• Andreasen PA, Riccio A, Welinder KG, et al. Plasminogen activator inhibitor type-1: reactive center and amino-terminal heterogeneity determined by protein and cDNA sequencing. Febs Lett. 1986;209(2):213–218.
   PubMed Web of Science ®Google Scholar
• Reilly CF, Fujita T, Mayer EJ, et al. Both circulating and clot-bound plasminogen activator inhibitor-1 inhibit endogenous fibrinolysis in the rat. Arterioscler Thromb. 1991;11(5):1276–1286.
   PubMedGoogle Scholar
• Ghosh AK, Vaughan DE. PAI-1 in tissue fibrosis. J Cell Physiol. 2012;227(2):493–507.
   PubMed Web of Science ®Google Scholar
• Gatto M, Iaccarino L, Ghirardello A, et al. Serpins, immunity and autoimmunity: old molecules, new functions. Clinic Rev Allerg Immunol. 2013;45(2):267–280.
   PubMed Web of Science ®Google Scholar
• Taphoorn MJ, Stupp R, Coens C, et al. Health-related quality of life in patients with glioblastoma: a randomised controlled trial. Lancet Oncol. 2005;6(12):937–944.
   PubMed Web of Science ®Google Scholar
• Izuhara K, Ohta S, Kanaji S, et al. Recent progress in understanding the diversity of the human ov-serpin/clade B serpin family. Cell Mol Life Sci. 2008;65(16):2541–2553.
   PubMed Web of Science ®Google Scholar
• Khan MS, Singh P, Azhar A, et al. Serpin inhibition mechanism: a delicate balance between native metastable state and polymerization. J Amino Acids. 2011;2011:1.
   Google Scholar
• Tsuruta JK, Eddy EM, O’Brien DA. Insulin-like growth factor-II/cation-independent mannose 6-phosphate receptor mediates paracrine interactions during spermatogonial development. Biol Reprod. 2000;63(4):1006–1013.
   PubMed Web of Science ®Google Scholar
• Bird CH, Sutton VR, Sun J, et al. Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway. Mol Cell Biol. 1998;18(11):6387–6398.
   PubMed Web of Science ®Google Scholar
• Hendel A, Hiebert PR, Boivin WA, et al. Granzymes in age-related cardiovascular and pulmonary diseases. Cell Death Differ. 2010;17(4):596–606.
   PubMed Web of Science ®Google Scholar
• Turner CT, Lim D, Granville DJ. Granzyme B in skin inflammation and disease. Matrix Biol. 2019;75–76:126–140. Jan
   PubMed Web of Science ®Google Scholar
• Fabricius D, Trzaska T, Fecher T, et al. Differential expression of serpins may selectively licence distinct granzyme B functions including antigen cross-presentation. Mol Immunol. 2017;87:325–326.
   PubMed Web of Science ®Google Scholar
• Hirst CE, Buzza MS, Bird CH, et al. The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency. J Immunol. 2003;170(2):805–815.
   PubMed Web of Science ®Google Scholar
• Motyka B, Korbutt G, Pinkoski MJ, et al. Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis. Cell. 2000;103(3):491–500.
   PubMed Web of Science ®Google Scholar
• Pinkoski MJ, Hobman M, Heibein JA, et al. Entry and trafficking of granzyme B in target cells during granzyme B-perforin-mediated apoptosis. Blood. 1998;92(3):1044–1054.
   PubMed Web of Science ®Google Scholar
• Shi L, Kraut RP, Aebersold R, et al. A natural killer cell granule protein that induces DNA fragmentation and apoptosis. J Exp Med. 1992;175(2):553–566.
   PubMed Web of Science ®Google Scholar
• Caputo A, James MN, Powers JC, et al. Conversion of the substrate specificity of mouse proteinase granzyme B. Nat Struct Mol Biol. 1994;1(6):364–367.
   Google Scholar
• Heusel JW, Wesselschmidt RL, Shresta S, et al. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell. 1994;76(6):977–987.
   PubMed Web of Science ®Google Scholar
• Darmon AJ, Nicholson DW, Bleackley RC. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature. 1995;377(6548):446–448.
   PubMed Web of Science ®Google Scholar
• Nakajima H, Park HL, Henkart PA. Synergistic roles of granzymes A and B in mediating target cell death by rat basophilic leukemia mast cell tumors also expressing cytolysin/perforin. J Exp Med. 1995;181(3):1037–1046.
   PubMed Web of Science ®Google Scholar
• Sun J, Ooms L, Bird CH, et al. A new family of 10 murine ovalbumin serpins includes two homologs of proteinase inhibitor 8 and two homologs of the granzyme B inhibitor (proteinase inhibitor 9). J Biol Chem. 1997;272(24):15434–15441.
   PubMed Web of Science ®Google Scholar
• Sun J, Whisstock JC, Harriott P, et al. Importance of the P4' residue in human granzyme B inhibitors and substrates revealed by scanning mutagenesis of the proteinase inhibitor 9 reactive center loop. J Biol Chem. 2001;276(18):15177–15184.
   PubMed Web of Science ®Google Scholar
• Cao X, Cai SF, Fehniger TA, et al. Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity. 2007;27(4):635–646.
   PubMed Web of Science ®Google Scholar
• Paydarnia N, Khoshtinat Nikkhoi S, Fakhravar A, et al. Synergistic effect of granzyme B-azurin fusion protein on breast cancer cells. Mol Biol Rep. 2019;46(3):3129–3140.
   PubMed Web of Science ®Google Scholar
• Amoury M, Kolberg K, Pham AT, et al. Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model. Cancer Lett. 2016;372(2):201–209.
   PubMed Web of Science ®Google Scholar
• Mikolajczyk SD, Marks LS, Partin AW, et al. Free prostate-specific antigen in serum is becoming more complex. Urology. 2002;59(6):797–802.
   PubMed Web of Science ®Google Scholar
• Stephan C, Jung K, Schnorr D, et al. Re: a prospective study to evaluate the role of complexed prostate specific antigen and free/total prostate specific antigen ratio for the diagnosis of prostate cancer. I.D.C. Mitchell, B.L. Croal, A. Dickie, N.P. Cohen and I. Ross. J Urol. 2001;165:1549–1553. J Urol. 2002 Jan;167(1):259-60.
   PubMed Web of Science ®Google Scholar
• Karashima S, Kataoka H, Itoh H, et al. Prognostic significance of alpha-1-antitrypsin in early stage of colorectal carcinomas. Int J Cancer. 1990;45(2):244–250.
   PubMed Web of Science ®Google Scholar
• Hurlimann J, van Melle G. Prognostic value of serum proteins synthesized by breast carcinoma cells. Am J Clin Pathol. 1991;95(6):835–843.
   PubMed Web of Science ®Google Scholar
• Zelvyte I, Wallmark A, Piitulainen E, et al. Increased plasma levels of serine proteinase inhibitors in lung cancer patients. Anticancer Res. 2004;24(1):241–247.
   PubMed Web of Science ®Google Scholar
• Tahara E, Ito H, Taniyama K, et al. Alpha 1-antitrypsin, alpha 1-antichymotrypsin, and alpha 2-macroglobulin in human gastric carcinomas: a retrospective immunohistochemical study. Hum Pathol. 1984;15(10):957–964.
   PubMed Web of Science ®Google Scholar
• Dano K, Andreasen PA, Grondahl-Hansen J, et al. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res. 1985;44:139–266.
   PubMed Web of Science ®Google Scholar
• Mignatti P, Rifkin DB. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev. 1993;73(1):161–195.
   PubMed Web of Science ®Google Scholar
• Chen D, Song M, Mohamad O, et al. Inhibition of Na+/K+-ATPase induces hybrid cell death and enhanced sensitivity to chemotherapy in human glioblastoma cells. BMC Cancer. 2014;14(1):716.
   PubMedGoogle Scholar
• Baker C, Belbin O, Kalsheker N, et al. SERPINA3 (aka alpha-1-antichymotrypsin). Front Biosci. 2007;12(8–12):2821–2835.
   PubMedGoogle Scholar
• Balch CM, Soong SJ. Predicting outcomes in metastatic melanoma. J Clin Oncol. 2008;26(2):168–169.
   PubMed Web of Science ®Google Scholar
• Eggermont AM, Spatz A, Robert C. Cutaneous melanoma. Lancet. 2014;383(9919):816–827.
   PubMed Web of Science ®Google Scholar
• Turnier JL, Brunner HI, Bennett M, et al. Discovery of SERPINA3 as a candidate urinary biomarker of lupus nephritis activity. Rheumatology (Oxford). 2019;58(2):321–330.
   PubMed Web of Science ®Google Scholar
• O'Riordan E, Orlova TN, Mei JJ, et al. Bioinformatic analysis of the urine proteome of acute allograft rejection. J Am Soc Nephrol. 2004;15(12):3240–3248.
   PubMed Web of Science ®Google Scholar
• O'Riordan E, Orlova TN, Podust VN, et al. Characterization of urinary peptide biomarkers of acute rejection in renal allografts. Am J Transplant. 2007;7(4):930–940.
   PubMed Web of Science ®Google Scholar
• Ziegler ME, Chen T, LeBlanc JF, et al. Apolipoprotein A1 and C-terminal fragment of alpha-1 antichymotrypsin are candidate plasma biomarkers associated with acute renal allograft rejection. Transplantation. 2011;92(4):388–395.
   PubMed Web of Science ®Google Scholar
• Porcellini E, Davis EJ, Chiappelli M, et al. Elevated plasma levels of alpha-1-anti-chymotrypsin in age-related cognitive decline and Alzheimer's disease: a potential therapeutic target. Curr Pharm Des . 2008;14(26):2659–2664.
   PubMed Web of Science ®Google Scholar
• Sergi D, Campbell FM, Grant C, et al. SerpinA3N is a novel hypothalamic gene upregulated by a high-fat diet and leptin in mice. Genes Nutr. 2018;13(1):28.
   PubMedGoogle Scholar
• Dalby MJ, Aviello G, Ross AW, et al. Diet induced obesity is independent of metabolic endotoxemia and TLR4 signalling, but markedly increases hypothalamic expression of the acute phase protein, SerpinA3N. Sci Rep. 2018;8(1):15648.
   PubMedGoogle Scholar
• Gueugneau M, d'Hose D, Barbe C, et al. Increased Serpina3n release into circulation during glucocorticoid-mediated muscle atrophy. J Cachexia Sarcopenia Muscle. 2018;9(5):929–946.
   PubMed Web of Science ®Google Scholar
• Kniesel U, Wolburg H. Tight junctions of the blood-brain barrier. Cell Mol Neurobiol. 2000;20(1):57–76.
   PubMed Web of Science ®Google Scholar
• Engelhardt B, Ransohoff RM. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol. 2005;26(9):485–495.
   PubMed Web of Science ®Google Scholar
• Pittock SJ, Lucchinetti CF. The pathology of MS: new insights and potential clinical applications. Neurologist. 2007;13(2):45–56.
   PubMed Web of Science ®Google Scholar
• Lu JQ, Fan Y, Mitha AP, et al. Association of alpha-synuclein immunoreactivity with inflammatory activity in multiple sclerosis lesions. J Neuropathol Exp Neurol. 2009;68(2):179–189.
   PubMed Web of Science ®Google Scholar
• Neumann H, Medana IM, Bauer J, et al. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci. 2002;25(6):313–319.
   PubMed Web of Science ®Google Scholar
• Chaitanya GV, Kolli M, Babu PP. Granzyme-b mediated cell death in the spinal cord-injured rat model. Neuropathology. 2009;29(3):270–279.
   PubMed Web of Science ®Google Scholar
• Russell JH, Ley TJ. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol. 2002;20(1):323–370.
   PubMedGoogle Scholar
• Bien CG, Vincent A, Barnett MH, et al. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain. 2012;135(5):1622–1638.
   PubMedGoogle Scholar
• Diotti RA, Nakanishi A, Clementi N, et al. JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes? Clin Dev Immunol. 2013;2013:1.
   Google Scholar
• Havla J, Kleiter I, Kumpfel T. Bridging, switching or drug holidays - how to treat a patient who stops natalizumab? Ther Clin Risk Manag. 2013;9:361–369.
   PubMed Web of Science ®Google Scholar
• Wuthrich C, Popescu BF, Gheuens S, et al. Natalizumab-associated progressive multifocal leukoencephalopathy in a patient with multiple sclerosis: a postmortem study. J Neuropathol Exp Neurol. 2013;72(11):1043–1051.
   PubMed Web of Science ®Google Scholar
• Tegeder I, Costigan M, Griffin RS, et al. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med. 2006;12(11):1269–1277.
   PubMed Web of Science ®Google Scholar
• Persson AK, Gebauer M, Jordan S, et al. Correlational analysis for identifying genes whose regulation contributes to chronic neuropathic pain. Mol Pain. 2009;5:7.
   PubMed Web of Science ®Google Scholar
• Costigan M, Belfer I, Griffin RS, et al. Multiple chronic pain states are associated with a common amino acid-changing allele in KCNS1. Brain. 2010;133(9):2519–2527.
   PubMed Web of Science ®Google Scholar
• Sorge RE, Trang T, Dorfman R, et al. Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity. Nat Med. 2012;18(4):595–599.
   PubMed Web of Science ®Google Scholar
• D'Andrea MR. Evidence linking neuronal cell death to autoimmunity in Alzheimer's disease. Brain Res. 2003;982(1):19–30.
   PubMed Web of Science ®Google Scholar
• Strous RD, Shoenfeld Y. To smell the immune system: olfaction, autoimmunity and brain involvement. Autoimmun Rev. 2006;6(1):54–60.
   PubMed Web of Science ®Google Scholar
• Zukor K, Belin S, Wang C, et al. Short hairpin RNA against PTEN enhances regenerative growth of corticospinal tract axons after spinal cord injury. J Neurosci. 2013;33(39):15350–15361.
   PubMed Web of Science ®Google Scholar
• Williams RR, Henao M, Pearse DD, et al. Permissive Schwann cell graft/spinal cord interfaces for axon regeneration. Cell Transplant. 2015;24(1):115–131.
   PubMed Web of Science ®Google Scholar
• Bush TG, Puvanachandra N, Horner CH, et al. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron. 1999;23(2):297–308. Jun
   PubMed Web of Science ®Google Scholar
• Faulkner JR, Herrmann JE, Woo MJ, et al. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci. 2004;24(9):2143–2155.
   PubMed Web of Science ®Google Scholar
• Wanner IB, Anderson MA, Song B, et al. Glial scar borders are formed by newly proliferated, elongated astrocytes that interact to corral inflammatory and fibrotic cells via STAT3-dependent mechanisms after spinal cord injury. J Neurosci. 2013;33(31):12870–12886.
   PubMed Web of Science ®Google Scholar
• Dringen R, Gutterer JM, Hirrlinger J. Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur J Biochem. 2000;267(16):4912–4916.
   PubMedGoogle Scholar
• Slemmer JE, Shacka JJ, Sweeney MI, et al. Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging. CMC. 2008;15(4):404–414.
   PubMed Web of Science ®Google Scholar
• Benarroch E. Endocannabinoids in basal ganglia circuits: implications for Parkinson disease. Neurology. 2007;69(3):306–309.
   PubMed Web of Science ®Google Scholar
• Adhami F, Yu D, Yin W, et al. Deleterious effects of plasminogen activators in neonatal cerebral hypoxia-ischemia. Am J Pathol. 2008;172(6):1704–1716.
   PubMed Web of Science ®Google Scholar
• Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol. 2010;119(1):7–35.
   PubMed Web of Science ®Google Scholar
• Valiente M, Obenauf AC, Jin X, et al. Serpins promote cancer cell survival and vascular co-option in brain metastasis. Cell. 2014;156(5):1002–1016.
   PubMed Web of Science ®Google Scholar
• Yepes M, Sandkvist M, Wong MK, et al. Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis. Blood. 2000;96(2):569–576.
   PubMed Web of Science ®Google Scholar
• Chia WJ, Dawe GS, Ong WY. Expression and localization of the iron-siderophore binding protein lipocalin 2 in the normal rat brain and after kainate-induced excitotoxicity. Neurochem Int. 2011;59(5):591–599.
   PubMed Web of Science ®Google Scholar
• Fukada Y, Yasui K, Kitayama M, et al. Gene expression analysis of the murine model of amyotrophic lateral sclerosis: studies of the Leu126delTT mutation in SOD1. Brain Res. 2007;1160:1–10.
   PubMed Web of Science ®Google Scholar
• Wang L, Jiang S, Xiao L, et al. Inhibition of granzyme B activity blocks inflammation induced by lipopolysaccharide through regulation of endoplasmic reticulum stress signaling in NK92 cells. Mol Med Rep. 2018;18(1):580–586.
   PubMed Web of Science ®Google Scholar
• Satta J, Laurila A, Paakko P, et al. Chronic inflammation and elastin degradation in abdominal aortic aneurysm disease: an immunohistochemical and electron microscopic study. Eur J Vasc Endovasc Surg. 1998;15(4):313–319. Apr
   PubMed Web of Science ®Google Scholar
• Ailawadi G, Eliason JL, Upchurch GR. Jr. Current concepts in the pathogenesis of abdominal aortic aneurysm. J Vasc Surg. 2003;38(3):584–588. Sep
   PubMed Web of Science ®Google Scholar
• Theocharis AD, Karamanos NK. Decreased biglycan expression and differential decorin localization in human abdominal aortic aneurysms. Atherosclerosis. 2002;165(2):221–230.
   PubMed Web of Science ®Google Scholar
• Boivin WA, Shackleford M, Vanden Hoek A, et al. Granzyme B cleaves decorin, biglycan and soluble betaglycan, releasing active transforming growth factor-beta1. PLoS One. 2012;7(3):e33163.
   PubMed Web of Science ®Google Scholar
• Afonina IS, Cullen SP, Martin SJ. Cytotoxic and non-cytotoxic roles of the CTL/NK protease granzyme B. Immunol Rev. 2010;235(1):105–116.
   PubMedGoogle Scholar
• Ewen CL, Kane KP, Bleackley RC. A quarter century of granzymes. Cell Death Differ. 2012;19(1):28–35. Jan
   PubMed Web of Science ®Google Scholar
• Susanto O, Trapani JA, Brasacchio D. Controversies in granzyme biology. Tissue Antigens. 2012;80(6):477–487.
   PubMedGoogle Scholar
• Hiebert PR, Wu D, Granville DJ. Granzyme B degrades extracellular matrix and contributes to delayed wound closure in apolipoprotein E knockout mice. Cell Death Differ. 2013;20(10):1404–1414.
   PubMed Web of Science ®Google Scholar
• Burr AR, Molkentin JD. Genetic evidence in the mouse solidifies the calcium hypothesis of myofiber death in muscular dystrophy. Cell Death Differ. 2015;22(9):1402–1412.
   PubMed Web of Science ®Google Scholar
• Hollinger K, Selsby JT. The physiological response of protease inhibition in dystrophic muscle. Acta Physiol. 2013;208(3):234–244.
   PubMed Web of Science ®Google Scholar
• Mantle D, Preedy VR. Adverse and beneficial functions of proteolytic enzymes in skeletal muscle. An overview. Adv Drug React Toxicol Rev. 2002;21(1–2):31–49.
   PubMedGoogle Scholar
• Li H, Mittal A, Makonchuk DY, et al. Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy. Hum Mol Genet. 2009;18(14):2584–2598.
   PubMed Web of Science ®Google Scholar
• Morris CA, Selsby JT, Morris LD, et al. Bowman-Birk inhibitor attenuates dystrophic pathology in mdx mice. J Appl Physiol (1985). 2010;109(5):1492–1499.
   PubMed Web of Science ®Google Scholar
• Regitz-Zagrosek V, Oertelt-Prigione S, Seeland U, et al. Sex and gender differences in myocardial hypertrophy and heart failure. Circ J. 2010;74(7):1265–1273.
   PubMed Web of Science ®Google Scholar
• Kania G, Blyszczuk P, Eriksson U. Mechanisms of cardiac fibrosis in inflammatory heart disease. Trends Cardiovasc Med. 2009;19(8):247–252.
   PubMed Web of Science ®Google Scholar
• Gjesdal O, Bluemke DA, Lima JA. Cardiac remodeling at the population level–risk factors, screening, and outcomes. Nat Rev Cardiol. 2011;8(12):673–685.
   PubMed Web of Science ®Google Scholar
• Nikolic I, Liu D, Bell JA, et al. Treatment with an estrogen receptor-beta-selective agonist is cardioprotective. J Mol Cell Cardiol. 2007;42(4):769–780.
   PubMed Web of Science ®Google Scholar
• Barth AS, Kuner R, Buness A, et al. Identification of a common gene expression signature in dilated cardiomyopathy across independent microarray studies. J Am Coll Cardiol. 2006;48(8):1610–1617. Oct 17
   PubMed Web of Science ®Google Scholar
• Asakura M, Kitakaze M. Global gene expression profiling in the failing myocardium. Circ J. 2009;73(9):1568–1576.
   PubMed Web of Science ®Google Scholar
• Ucer S, Iyer S, Kim HN, et al. The effects of aging and sex steroid deficiency on the murine skeleton are independent and mechanistically distinct. J Bone Miner Res. 2017;32(3):560–574.
   PubMed Web of Science ®Google Scholar
• Kaufman RJ. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev. 1999;13(10):1211–1233.
   PubMed Web of Science ®Google Scholar
• Roger VL, Go AS, Lloyd-Jones DM, et al. Executive summary: heart disease and stroke statistics–2012 update: a report from the American Heart Association. Circulation. 2012;125(1):188–197.
   PubMed Web of Science ®Google Scholar
• Marcet-Palacios M, Ewen C, Pittman E, et al. Design and characterization of a novel human Granzyme B inhibitor. Protein Eng Des Sel. 2015;28(1):9–17.
   PubMed Web of Science ®Google Scholar
• Gardill BR, Schmidt K, Muller YA. NewBG: A surrogate corticosteroid-binding globulin with an unprecedentedly high ligand release efficacy. J Struct Biol. 2019;207(2):169–182.
   PubMed Web of Science ®Google Scholar
• Schmidt K, Gardill BR, Kern A, et al. Design of an allosterically modulated doxycycline and doxorubicin drug-binding protein. Proc Natl Acad Sci USA. 2018;115(22):5744–5749.
   PubMed Web of Science ®Google Scholar